Bioavailability of Quercetin: Problems and Promises

被引:326
作者
Cai, X. [1 ]
Fang, Z. [2 ]
Dou, J. [1 ]
Yu, A. [1 ]
Zhai, G. [1 ]
机构
[1] Shandong Univ, Coll Pharm, Dept Pharmaceut, Jinan 250012, Peoples R China
[2] Shandong Univ, Coll Pharm, Minist Educ, Dept Med Chem,Key Lab Chem Biol, Jinan 250012, Peoples R China
关键词
Bioavilability; formulations; inclusion complexes; liposomes; micelles; nanoparticles; prodrug; quercetin; solubility; SOLID LIPID NANOPARTICLES; POORLY SOLUBLE DRUGS; IN-VITRO EVALUATION; LIPOSOMAL QUERCETIN; POLYMERIC MICELLES; GROWTH-INHIBITION; FORMULATION; DELIVERY; CANCER; SOLUBILIZATION;
D O I
10.2174/09298673113209990120
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Quercetin (QC) is a typical plant flavonoid, possesses diverse pharmacologic effects including anti-inflammatory, antioxidant, anti-cancer, anti-anaphylaxis effects and against aging. However, the application of QC in pharmaceutical field is limited due to its poor solubility, low bioavailability, poor permeability and instability. To improve the bioavailability of QC, numerous approaches have been undertaken, involving the use of promising drug delivery systems such as inclusion complexes, liposomes, nanoparticles or micelles, which appear to provide higher solubility and bioavailability. Enhanced bioavailability of QC in the near future is likely to bring this product to the forefront of therapeutic agents for treatment of human disease.
引用
收藏
页码:2572 / 2582
页数:11
相关论文
共 94 条
[1]   Preparation, Characterization, and DNA Binding Studies of Water-Soluble Quercetin-Molybdenum(VI) Complex [J].
Ahmadi, Seyed Mojtaba ;
Dehghan, Gholamreza ;
Hosseinpourfeizi, Muhammad Ali ;
Dolatabadi, Jafar Ezzati Nazhad ;
Kashanian, Soheila .
DNA AND CELL BIOLOGY, 2011, 30 (07) :517-523
[2]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[3]   Bioavailability of curcumin: Problems and promises [J].
Anand, Preetha ;
Kunnumakkara, Ajaikumar B. ;
Newman, Robert A. ;
Aggarwal, Bharat B. .
MOLECULAR PHARMACEUTICS, 2007, 4 (06) :807-818
[4]   Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration [J].
Bala, I ;
Bhardwaj, V ;
Hariharan, S ;
Kharade, SV ;
Roy, N ;
Kumar, MNVR .
JOURNAL OF DRUG TARGETING, 2006, 14 (01) :27-34
[5]   DIFFUSION OF UNIVALENT IONS ACROSS LAMELLAE OF SWOLLEN PHOSPHOLIPIDS [J].
BANGHAM, AD ;
STANDISH, MM ;
WATKINS, JC .
JOURNAL OF MOLECULAR BIOLOGY, 1965, 13 (01) :238-+
[6]   Formulation and characterization of polyphenol-loaded lipid nanocapsules [J].
Barras, A. ;
Mezzetti, A. ;
Richard, A. ;
Lazzaroni, S. ;
Roux, S. ;
Melnyk, P. ;
Betbeder, D. ;
Monfilliette-Dupont, N. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2009, 379 (02) :270-277
[7]  
Bhattaram VA, 2002, PHYTOMEDICINE, V9, P1
[8]   Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles [J].
Bilati, U ;
Allémann, E ;
Doelker, E .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 24 (01) :67-75
[9]   Effect of quercetin on inflammatory gene expression in mice liver in vivo - role of redox factor 1, miRNA-122 and miRNA-125b [J].
Boesch-Saadatmandi, Christine ;
Wagner, Anika E. ;
Wolffram, Siegfried ;
Rimbach, Gerald .
PHARMACOLOGICAL RESEARCH, 2012, 65 (05) :523-530
[10]   Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis [J].
Boots, Agnes W. ;
Drent, Marjolein ;
de Boer, Vincent C. J. ;
Bast, Aalt ;
Haenen, Guido R. M. M. .
CLINICAL NUTRITION, 2011, 30 (04) :506-512